Beijing Hotgen Biotech Co., Ltd. (SHA:688068)

Beijing Hotgen Biotech Revenue

Beijing Hotgen Biotech had revenue of 110.67M CNY in the quarter ending June 30, 2025, a decrease of -16.59%. This brings the company's revenue in the last twelve months to 466.00M, down -4.83% year-over-year. In the year 2024, Beijing Hotgen Biotech had annual revenue of 510.90M, down -6.74%.

• Revenue (ttm): 466.00M
• Revenue Growth: -4.83%
• P/S Ratio: 32.39
• Revenue / Employee: n/a
• Employees: 903
• Market Cap: 15.09B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	510.90M	-36.94M	-6.74%
Dec 31, 2023	547.84M	-3.01B	-84.60%
Dec 31, 2022	3.56B	-1.81B	-33.76%
Dec 31, 2021	5.37B	4.86B	945.54%
Dec 31, 2020	513.53M	303.12M	144.06%